Cambium Bio Limited has released a press release.
Response to ASX Appendix 4C Query
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Cambium Bio
- Appendix 4C - Quarterly Report
- Clarification on Quarterly Activity Report and Appendix 4C
- CEO Appointment and Resignation
- Regeneus receives $5.6M milestone payment from Kyocera
- Regeneus to be granted new Sygenus patent in Canada
Later from Cambium Bio
- Regeneus to be granted new patent to target pain in Japan
- Appendix 4D and Half-Year Report
- Half-Year Results and Business Update
- Regeneus Company Update Investor Webcast Presentation
- Regeneus to be granted key Progenza patent in Europe
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio